12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia |
|
The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes |
|
The accuracy of a new real-time continuous glucose monitoring algorithm: an analysis |
|
The artificial pancreas: a digital-age treatment for diabetes |
|
Assessment of behavioral mechanisms maintaining encopresis: Virginia Encopresis-Constipation Apperception Test |
|
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range |
|
The closed-loop artificial pancreas in 2020 |
|
Closed-Loop Control Performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System in a Feasibility Study. |
|
Continuous Glucose Sensors: Continuing Questions about Clinical Accuracy |
|
A critical appraisal of the continuous glucose-error grid analysis: response to Wentholt et al. |
|
Detection of hypoglycemia by children with type 1 diabetes 6 to 11 years of age and their parents: a field study |
|
Development of the Diabetes Technology Society Blood Glucose Monitor System Surveillance Protocol |
|
Diabetes: Models, Signals, and Control |
|
DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials |
|
The Differential and Combined Action of Insulin Glargine and Lixisenatide on the Fasting and Postprandial Components of Glucose Control |
|
Does "stubbornness" have a role in pediatric constipation? |
|
Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes |
|
The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes. |
|
Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time in Range All We Need? |
|
Evaluating the efficacy of closed-loop glucose regulation via control-variability grid analysis |
|
Future of Automated Insulin Delivery Systems |
|
Glucose Variability and Mortality in Patients Hospitalized With Acute Myocardial Infarction |
|
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings |
|
Glycemic Variability: Risk Factors, Assessment, and Control |
|
Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus |
|
Hypoglycemia preceding fatal car collisions |
|
Hypoglycemia risk and glucose variability indices derived from routine self-monitoring of blood glucose are related to laboratory measures of insulin sensitivity and epinephrine counterregulation |
|
In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies |
|
In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes |
|
In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes |
|
An Internet intervention as adjunctive therapy for pediatric encopresis |
|
Is Psychological Stress a Factor for Incorporation Into Future Closed-Loop Systems? |
|
Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes. |
|
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes |
|
A model of self-treatment behavior, glucose variability, and hypoglycemia-associated autonomic failure in type 1 diabetes |
|
Multinational Home Use of Closed-Loop Control Is Safe and Effective |
|
Novel methodology to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system |
|
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report |
|
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes |
|
Patient perspectives on personalized glucose advisory systems for type 1 diabetes management |
|
Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology |
|
Randomized Controlled Trial of Mobile Closed-Loop Control |
|
Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine |
|
Remote glucose monitoring in cAMP setting reduces the risk of prolonged nocturnal hypoglycemia |
|
Response to Comment on Kovatchev and Cobelli. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes. Diabetes Care 2016;39:502-510. |
|
Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial |
|
Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor |
|
Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus |
|
The surveillance error grid |
|
Treatment of childhood constipation by primary care physicians: efficacy and predictors of outcome. |
|
Treatment of childhood encopresis: a randomized trial comparing three treatment protocols |
|
Using the internet to provide information prescriptions. |
|
The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day. |
|